| Document Date: 2010-10-20 06:13:43
Open Document File Size: 933,79 KBShare Result on Facebook
City Kyoto / Kobe / Shanghai / Beijing / / Company Ranbaxy / MGI Pharma / Millennium / EU Germany 2008 Daiichi-Sankyo / Eisai / Czechoslovakia 2008 Otsuka / Paradigm Therapeutics India 2008 Daiichi-Sankyo / GlaxoSmithKline UK / EU 2007 Takeda / Morphotek 2004 Takeda / Merck US / US 2008 Takeda / Pfizer US / / Continent Asia / Europe / / Country Germany / France / Japan / United States / Brazil / Italy / Canada / Korea / United Kingdom / China / Singapore / Spain / / Currency USD / / Event Reorganization / Business Partnership / M&A / Company Expansion / / Facility R&D headquarters / / IndustryTerm bulk drug substance manufacturing / pharmaceutical market / manufacturing / / MedicalCondition malignant tumors / viral diseases / Tropical diseases / / Organization Association of Southeast Asian Nations / European Union / / ProvinceOrState Saitama Prefecture / / Region Oceania / / Technology drug discovery / drug development / / URL http /
SocialTag |
Why Need Globalize R&D? uExpansion to regions with attractive R&D resources -Excellent human resources, high-level research/skills, government programs/support